Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Weekly Roundup – June 9, 2022 

View this email in your browser Weekly Roundup – June 9, 2022                            For the...

| By Kelley Gipson

Yale researchers study protein’s role in lupus

Between 5-8% of the human genome consists of sequences with viral origin, namely endogenous retroviruses. Their RNA expression has been correlated with several diseases, including...

| By Kelley Gipson

UConn Health adds to reputation for excellence

The National Accreditation Program for Breast Centers has granted accredited status to the UConn Health Carole and Ray Neag Comprehensive Cancer Center. To achieve voluntary NAPBC accreditation,...

| By Kelley Gipson

Career News – June 7, 2022 

View this email in your browser Career News – June 7, 2022  Our new Career Portal is now active!  We are thrilled to announce the...

| By Kelley Gipson

IsoPlexis Functional Cell Library adds data

IsoPlexis developed a new library of cells characterized by functional proteomics to complement the Genomic Cell Atlas. The Functional Cell Library adds a unique layer of...

| By Kelley Gipson

Agricultural AI is creating a resilient food system

Growers have always been tech savvy, but autonomous tractors, robots tending to crops, and drones precisely dispersing inputs are a big leap forward from 20th-century...

| By Kelley Gipson

ViiV, Horizon, Pfizer earn top patient scores

When it comes to sizing up pharma’s corporate reputation, U.S. patient groups put GlaxoSmithKline’s ViiV Healthcare, Horizon Therapeutics and Pfizer on top. The trio nabbed first, second...

| By Kelley Gipson

InveniAI®, Kyowa Kirin reach research milestone

InveniAI® has received a milestone payment from Kyowa Kirin under the research collaboration between the companies. Yoshifumi Torii, Ph.D., Executive Officer, Vice President, and Head of...

| By Kelley Gipson

Weekly Roundup – June 2, 2022 

View this email in your browser Weekly Roundup – June 2, 2022                           ...

| By Kelley Gipson

FDA clears two Lumendi medical devices

Westport-based medical device provider Lumendi has filed for FDA clearance for DiLumen EZ, a single-use, disposable endotherapy device intended for endoscopic mucosal resections (EMR) and difficult colonoscopies. “EMR...